|
| Scientific Program |
| |
|
| Scientific Program | Search Abstract |
| |
|
|
| Session |
| |
| Red blood cells and Iron I |
| Date: |
Friday, 05 June 2009
|
| Time: | 17:45-19:00 |
| Room: | |
| |
| 17:45-19:00 |
|
EFFICACY AND SAFETY OF DEFERASIROX IN REDUCING MYOCARDIAL SIDEROSIS IN PATIENTS WITH ?-THALASSAEMIA MAJOR
| 0193 |
| Pennell, Dudley,
Porter, John B.,
Cappellini, Maria Domenica,
Chan, Lee Lee,
El-Beshlawy, Amal,
Aydinok, Yesim,
Ibrahim, Hishamshah,
Li, Chi-Kong,
Viprakasit, Vip,
Elalfy, Mohsen,
Kattamis, Antonis,
Smith, Gillian,
Habr, Dany,
Domokos, Gabor,
Hmissi, Abdel,
Taher, Ali
(London, United Kingdom) |
| |
| 17:45-19:00 |
|
LABILE PLASMA IRON LEVELS IN HEAVILY IRON-OVERLOADED PATIENTS WITH TRANSFUSION-DEPENDENT ANAEMIAS IN RESPONSE TO DEFERASIROX THERAPY: RESULTS FROM THE LARGE-SCALE, PROSPECTIVE 1-YEAR EPIC TRIAL
| 0194 |
| Kattamis, Antonis,
El-Beshlawy, Amal,
Seymour, John F.,
Li, Chi-Kong,
Nick, Hanspeter,
Habr, Dany,
Domokos, Gabor,
Roubert, Bernard,
Cappellini, Maria Domenica
(Athens, Greece) |
| |
| 17:45-19:00 |
|
THE EFFICACY OF IRON CHELATOR REGIMES IN REDUCING CARDIAC AND HEPATIC IRON IN PATIENTS WITH THALASSAEMIA MAJOR: A CLINICAL OBSERVATIONAL STUDY
| 0195 |
| Berdoukas, Vasilios,
Chouliaras, Giorgos ,
Moraitis, Panagiotis,
Zannikos, Kirykos ,
Berdoussi, Eleni,
Ladis, Vassilis
(ATHENS, Greece) |
| |
| 17:45-19:00 |
|
INCREASED PLASMA LEVELS OF NGAL AND IL-18 CORRELATE WITH REDUCED GFR PROVIDING EVIDENCE OF TUBULOGLOMERULAR DEFECT IN PATIENTS WITH HBS/BETA-THALASSEMIA
| 0196 |
| Papassotiriou, Ioannis,
Margeli, Alexandra ,
Hantzi, Eugenia ,
Terpos, Evangelos,
Voskaridou, Ersi
(Athens, Greece) |
| |
| 17:45-19:00 |
|
ANALYSIS OF IRON HOMEOSTASIS AND ERYTHROID ACTIVITY IN A COHORT OF LOW-RISK MYELODYSPLASTIC PATIENTS
| 0197 |
| Messa, Emanuela,
Maffè, Chiara,
Volpe, Gisella,
Campostrini, Natascia,
Gioia, Daniela,
Levis, Alessandro,
Cilloni, Daniela,
Girelli, Domenico,
Camaschella, Clara,
Saglio, Giuseppe
(Orbassano, Italy) |
| |
| 17:45-19:00 |
|
MYOCARDIAL LESIONS AND IRON DEPOSITS AFTER TREATMENT WITH ANTHRACYCLINES
| 0198 |
| CASCALES, ALMUDENA,
PASTOR, F.,
SANCHEZ-VEGA, B.,
CORRAL, J,
VICENTE, V.,
AYALA, F.
(MURCIA, Spain) |
| |
| 17:45-19:00 |
|
ASSESSMENT OF SAFETY IN PATIENTS RECEIVING LONGER-TERM IRON CHELATION THERAPY WITH DEFERASIROX WHO HAD ACHIEVED SERUM FERRITIN LEVELS OF <1000 NG/ML DURING THE STUDY COURSE
| 0199 |
| Porter, John,
Piga, Antonio,
Cohen, Alan,
Ford, John M.,
Bodner, Janet,
Cappellini, Maria Domenica
(London, United Kingdom) |
| |
| 17:45-19:00 |
|
SAFETY AND EFFICACY OF IRON CHELATION THERAPY WITH DEFERASIROX IN PATIENTS WITH SICKLE CELL DISEASE (SCD): 3.5-YEAR FOLLOW-UP
| 0200 |
| Vichinsky, Elliott,
Coates, Thomas,
Thompson, Alexis,
Bernaudin, Françoise,
Lagrone, Darlene,
Dong, Victor,
Heeney, Matthew
(Oakland, CA, United States of America) |
| |
| 17:45-19:00 |
|
DEFERASIROX IN PAEDIATRIC PATIENTS WITH THALASSAEMIA MAJOR: 1-YEAR RESULTS FROM A LARGE PAEDIATRIC COHORT ENROLLED IN THE PROSPECTIVE, MULTICENTRE EPIC STUDY
| 0201 |
| Filosa, Aldo,
Elalfy, Mohsen,
Li, Chunfu,
Lai, Yongrong,
Chan, Lee Lee,
Sutcharitchan, Pranee,
Habr, Dany,
Domokos, Gabor,
Roubert, Bernard,
El-Beshlawy, Amal
(Naples, Italy) |
| |
| 17:45-19:00 |
|
DELETION IN THE LDLR1 & 2 DOMAINS IN THE TMPRSS6 GENE IN A CHILD CAUSES IRIDA WITH EXTREMELY HIGH HEPCIDIN LEVEL
| 0202 |
| Tchou, Isabelle,
Diepold , Miriam MD,
Neerman-Arbez, Marguerite MD,
Beris, Photis MD (P)
(Geneva, Switzerland) |
| |
| 17:45-19:00 |
|
OUTCOMES OF PATIENTS WITH SICKLE CELL DISEASE ADMITTED TO THE INTENSIVE THERAPY UNIT – A SINGLE INSTITUTION EXPERIENCE
| 0203 |
| Gardner, Kate,
Bell, Cathy,
Allman, Marlene,
Ervine, Max,
Thein, Swee Lay,
Awogbade, Moji
(London, United Kingdom) |
| |
| 17:45-19:00 |
|
TREATMENT WITH DEFERASIROX EFFECTIVELY DECREASES IRON BURDEN IN PATIENTS WITH THALASSEMIA INTERMEDIA
| 0204 |
| Voskaridou, Ersi,
Konstantinidou, M.,
Douskou, M.,
Plata, E.,
Papadakis, M.,
Delaki, E.E.,
Christoulas, D.,
Terpos, E.
(Athens, Greece) |
| |
| 17:45-19:00 |
|
ACUTE SPLENIC SEQUESTRATION IN SICKLE CELL DISEASE (SCD)
| 0205 |
| Brousse, Valentine,
Lesprit, E.,
Bernaudin, F.,
Odievre, M.H.,
Guitton, C.,
Quinet, B.,
Dangiolo, S.,
De Montalembert, M.
(Paris, France) |
| |
| 17:45-19:00 |
|
IRON CHELATION THERAPY WITH DEFERASIROX FOR TRANSFUSIONAL IRON-OVERLOADED PATIENTS WITH APLASTIC ANAEMIA AND OTHER RARE ANAEMIAS
| 0206 |
| Porter, John,
Yoon, Sung-Soo,
Shen, Zhi Xiang,
Thein, Swee Lay,
Lin, Kai-Hsin,
Habr, Dany,
Domokos, Gabor,
Roubert, Bernard,
Lee, Jong Wook
(London, United Kingdom) |
| |
| 17:45-19:00 |
|
A CLOSER LOOK AT CELLULAR IRON METABOLISM IN IRP2 DEFICIENT ERYTHROBLASTS
| 0207 |
| Schranzhofer, Matthias,
Galy, Bruno,
Schifrer, Manfred,
Hentze, Matthias,
Muellner, Ernst,
Ponka, Prem
(Montreal, Canada) |
| |
| 17:45-19:00 |
|
ASSESSMENT OF NON-TRANSFERRIN BOUND IRON IN THALASSEMIC SERA USING A NEW FLUORESCENCE BASED ASSAY
| 0208 |
| Gohil, Nivedita K,
Sharma, Manisha,
Saxena, Renu (P)
(New Delhi, India) |
| |
| 17:45-19:00 |
|
DEFERASIROX SIGNIFICANTLY REDUCES IRON BURDEN IN HEAVILY IRON-OVERLOADED PATIENTS WITH BETA-THALASSAEMIA: 2.7 YEAR RESULTS FROM THE ESCALATOR STUDY
| 0209 |
| Taher, Ali,
El-Beshlawy, Amal,
Elalfy, Mohsen,
Al Zir, Kusai,
Daar, Shahina,
Habr, Dany,
Kriemler-Krahn, Ulrike,
Roubert, Bernard,
Al Jefri, Abdullah
(Beirut, Lebanon) |
| |
|